The population enrolled in this study are all subjects who received an Impella in which a bicarbonate-based purge solution was used.
Study Type
OBSERVATIONAL
Enrollment
312
US commercially approved Abiomed left sided hemodynamic support devices (Impella) will be included.
US commercially approved Abiomed right sided hemodynamic support devices (Impella) will be included.
University of Alabama
Birmingham, Alabama, United States
Pima Heart and Vascular (Tuscon Medical Center)
Tucson, Arizona, United States
Primary Endpoint Left Sided Impella
Rate of heiarchical composite of stroke, transient ischemic attack (TIA), left ventricular (LV) thrombus
Time frame: From hospital admission until hospital discharge, average 5 days
Primary Endpoint Right Sided Impella
Rate of heiarchical composite of pulmonary thromboemboli and deep vein thrombosis (DVT)
Time frame: From hospital admission until hospital discharge, average 5 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Arkansas Heart Hospital
Little Rock, Arkansas, United States
Keck USC Medical Center
Los Angeles, California, United States
Advent Helath Orlando
Orlando, Florida, United States
Tampa General Hospital
Tampa, Florida, United States
Henry Ford
Detroit, Michigan, United States
Ascension St. John Hospital
Detroit, Michigan, United States
Providence St. Patrick
Missoula, Montana, United States
University of Nebraska
Omaha, Nebraska, United States
...and 10 more locations